Literature DB >> 821963

Suppression of prolactin secretion by L-dopa in the stalk-sectioned rhesus monkey.

W P Diefenbach, P W Carmel, A G Frantz, M Ferin.   

Abstract

The effects of iv administration of L-dopa on serum prolactin were studied in both normal female rhesus monkeys and in monkeys in which the pituitary stalk had been previously sectioned. Revascularization of the pituitary gland was prevented by the insertion of a silastic barrier over the diaphragma sellae. Prolactin secretion was increased in all stalk-sectioned monkeys and, in contrast to intact animals, chlorpromazine administration was ineffective in further releasing prolactin. In both normal and stalk-sectioned monkeys, iv administration of L-dopa (3-120 mg) significantly inhibited prolactin release from the pituitary (P less than .005 normal; P less than .001 stalk section). L-dopa also suppressed the TRH-induced release of prolactin in both groups. These results indicate that L-dopa or dopamine may act directly on the anterior pituitary to inhibit prolactin secretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821963     DOI: 10.1210/jcem-43-3-638

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

2.  [Hyperprolactinemia and sterility].

Authors:  H K Rjosk; R Fahlbusch; K von Werder
Journal:  Arch Gynecol       Date:  1979-07-20

3.  Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

Authors:  S A Fine; L A Frohman
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

4.  The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.

Authors:  M K Jones; I D Ramsay; P G Jenner
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

5.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

Review 6.  [Human prolactin (author's transl)].

Authors:  K von Werder; H K Rjosk
Journal:  Klin Wochenschr       Date:  1979-01-01

Review 7.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

8.  Amplification of LH response to LHRH by dopamine infusion in eugonadal women.

Authors:  E Pucci; F Franchi; P M Kicovic; R Sgrilli; D Barletta; G F Argenio; M Gasperi; G P Bernini; M Luisi
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.